Åsa Konradsson Geuken

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF NEURAL TRANSMISSION. 2015;122(2):259-272
Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor
Malmlof T; Feltmann K; Konradsson-Geuken A; Schneider F; Alken R-G; Svensson TH; Schilstrom B
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2014;18(3):pyu068
Adjunctive Treatment with Asenapine Augments the Escitalopram-Induced Effects on Monoaminergic Outflow and Glutamatergic Neurotransmission in the Medial Prefrontal Cortex of the Rat
Bjorkholm C; Franberg O; Malmerfelt A; Marcus MM; Konradsson-Geuken A; Schilstrom B; Jardemark K; Svensson TH
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013;16(9):2041-2051
Hippocampal and prefrontal dopamine D_1/5 receptor involvement in the memory-enhancing effect of reboxetine
De Bundel D; Femenia T; DuPont CM; Konradsson-Geuken A; Feltmann K; Schilstrm B; Lindskog M
Article: SYNAPSE. 2012;66(4):277-290
Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: Behavioral, biochemical, and electrophysiological evidence
Marcus MM; Jardemark K; Malmerfelt A; Gertow J; Konradsson-Geuken A; Svensson TH
Article: SYNAPSE. 2011;65(5):357-367
Effects of S-Citalopram, Citalopram, and R-Citalopram on the Firing Patterns of Dopamine Neurons in the Ventral Tegmental Area, N-methyl-D-aspartate Receptor-Mediated Transmission in the Medial Prefrontal Cortex and Cognitive Function in the Rat
Schilstrom B; Konradsson-Geuken A; Ivanov V; Gertow J; Feltmann K; Marcus MM; Jardemark K; Svensson TH
Article: NEUROSCIENCE. 2010;169(4):1848-1859
CORTICAL KYNURENIC ACID BI-DIRECTIONALLY MODULATES PREFRONTAL GLUTAMATE LEVELS AS ASSESSED BY MICRODIALYSIS AND RAPID ELECTROCHEMISTRY
Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2010;13(7):891-903
Adjunctive α₂-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission
Marcus MM; Wiker C; Franberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
Article: SYNAPSE. 2009;63(12):1069-1082
Second-by-Second Analysis of Alpha 7 Nicotine Receptor Regulation of Glutamate Release in the Prefrontal Cortex of Awake Rats
Konradsson-Geuken A; Gash CR; Alexander K; Pomerleau F; Huettl P; Gerhardt GA; Bruno JP
Article: SYNAPSE. 2009;63(10):913-920
Differential Effects of Topiramate on Prefrontal Glutamatergic Transmission When Combined With Raclopride or Clozapine
Jardemark KE; Konradsson A; Schilstrom B; Marcus MM; Svensson TH
Article: PSYCHOPHARMACOLOGY. 2008;196(3):417-429
Asenapine, a novel psychopharmacologic agent:: preclinical evidence for clinical effects in schizophrenia
Franberg O; Wiker C; Marcus MM; Konradsson A; Jardemark K; Schilstrom B; Shahid M; Wong EHF; Svensson TH
Article: SYNAPSE. 2006;60(2):102-108
Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex
Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2005;8(2):157-162
The combination of nicotine with the D₂ antagonist raclopride or the weak D₄ antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex
Jardemark K; Marcus MM; Konradsson Å; Svensson TH

Alla övriga publikationer

Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2009;19:S562-S563
Enhanced cortical dopaminergic and glutamatergic transmission and antipsychotic-like effect of risperidone by idazoxan
Marcus MM; Wiker C; Franberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
Thesis / dissertation: 2007
Modulation of prefrontal glutamatergic transmission and 'atypicality' of antipsychotic drugs
Konradsson, Åsa
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S477
Asenapine:: preclinical evidence for clinical effects in schizophrenia and cognitive dysfunction
Svensson TH; Frånberg O; Konradsson A; Jardemark K; Schilstroem B; Wiker C; Ivanov V; Shahid M; Wong EHF; Marcus MM
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S33-S34
Adjuvant treatment with the anticonvulsant drug topiramate in schizophrenia
Konradsson A; Marcus MM; Sitzia R; Svensson TH; Jardemark KE
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2007;17:S20-S21
Asenapine: preclinical evidence for clinical effects in Schizophrenia
Franberg O; Marcus MM; Konradsson A; Jardemark K; Schilstrom B; Wiker C; Shahid M; Wong EHF; Svensson TH
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2006;16:s30-s31
Inhibition of glycine uptake augments risperidone's effect on prefrontal glutamatergic transmission
Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2003;13:s301
Addition of nicotine to the D₂ antagonist raclopride or the weak D₄ antagonist L-745,870 augments NMDA-induced currents in pyramidal cells from the rat medial prefrontal cortex
Marcus MM; Jardemark KE; Konradsson Å; Svensson TH

Anställningar

Anknuten till Forskning, Fysiologi och farmakologi, Karolinska Institutet, 2023-2025

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för fysiologi och farmakologi, Karolinska Institutet, 2007
Medicine Kandidatexamen, Karolinska Institutet, 2001
Biomedicinsk Analytikerexamen, Karolinska Institutet, 2001

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI